| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-12 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.32 | 1e-09 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-08 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-07 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |